Compounds > n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine
Page last updated: 2024-11-05

n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine and Cancer of Kidney

n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine has been researched along with Cancer of Kidney in 1 studies

N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine: a zinc ion chelating agent; structure given in first source
N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine : An N-substituted diamine that is ethylenediamine in which the four amino hydrogens are replaced by 2-pyridylmethyl groups.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kolenko, V1
Uzzo, RG1
Bukowski, R1
Bander, NH1
Novick, AC1
Hsi, ED1
Finke, JH1

Other Studies

1 other study available for n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine and Cancer of Kidney

ArticleYear
Dead or dying: necrosis versus apoptosis in caspase-deficient human renal cell carcinoma.
    Cancer research, 1999, Jun-15, Volume: 59, Issue:12

    Topics: Apoptosis; Carcinoma, Renal Cell; Caspases; Cholinesterase Inhibitors; Ethylenediamines; Humans; Jur

1999